Emerging and Investigational Therapies for Multiple Myeloma

Source: Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address the Paradox of Choice
Download Slideset
Download this slideset based on the content from a live-stream CCO series from Nina Shah, MD on novel therapies under investigation for patients with relapsed/refractory multiple myeloma, including CAR T-cell therapies, bispecific antibodies, antibody drug conjugates, and CELMoDs.
Nina Shah, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.07 MB
Released: June 24, 2021

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
GlaxoSmithKline
Karyopharm
Oncopeptides
Sanofi Genzyme

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings